Stylianos Kakolyris

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Mantatzis Michael; Kakolyris Stylianos; Amarantidis Kyriakos; Karayiannakis Anastasios; Prassopoulos Panos
Treatment response classification of liver metastatic disease evaluated on imaging. Are RECIST unidimensional measurements accurate?
Xenidis Nikolaos; Ignatiadis Michail; Apostolaki Stella; Perraki Maria; Kalbakis Kostas; Agelaki Sofia; Stathopoulos Efstathios N; Chlouverakis Grigorios; Lianidou Evi; Kakolyris Stylianos; Georgoulias Vassilis; Mavroudis Dimitris
Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.
Simopoulos Constantinos; Christodoulou Eirini; Lambropoulou Maria; Tsaroucha Alexandra K; Kakolyris Stylianos; Polychronidis Alexandros; Karayiannakis Anastasios J; Chatzaki Ekaterini
Neuropeptide urocortin 1 and its receptors are expressed in the human liver.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Stylianos Kakolyris (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Mantatzis Michael; Kakolyris Stylianos; Amarantidis Kyriakos; Karayiannakis Anastasios; Prassopoulos Panos
Treatment response classification of liver metastatic disease evaluated on imaging. Are RECIST unidimensional measurements accurate?
European radiology 2009;19(7):1809-16.
2009: Xenidis Nikolaos; Ignatiadis Michail; Apostolaki Stella; Perraki Maria; Kalbakis Kostas; Agelaki Sofia; Stathopoulos Efstathios N; Chlouverakis Grigorios; Lianidou Evi; Kakolyris Stylianos; Georgoulias Vassilis; Mavroudis Dimitris
Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(13):2177-84.
2009: Simopoulos Constantinos; Christodoulou Eirini; Lambropoulou Maria; Tsaroucha Alexandra K; Kakolyris Stylianos; Polychronidis Alexandros; Karayiannakis Anastasios J; Chatzaki Ekaterini
Neuropeptide urocortin 1 and its receptors are expressed in the human liver.
Neuroendocrinology 2009;89(3):315-26.
2008: Gioulbasanis Ioannis; Saridaki Zacharenia; Kalykaki Antonia; Vamvakas Lambros; Kalbakis Kostas; Ignatiadis Michail; Amarantidis Kyriakos; Kakolyris Stylianos; Georgoulias Vassilis; Mavroudis Dimitris
Gefitinib in combination with gemcitabine and vinorelbine in patients with metastatic breast cancer pre-treated with taxane and anthracycline chemotherapy: a phase I/II trial.
Anticancer research 2008;28(5B):3019-25.
2008: Pallis Athanasios G; Polyzos Aris; Boukovinas Ioannis; Agelidou Athina; Lamvakas Lambros; Tsiafaki Xanthi; Agelidou Maria; Pavlakou Georgia; Chandrinos Vassilis; Kakolyris Stelios; Christophyllakis Charalambos; Kentepozidis Nikolaos; Giassas Stelios; Androulakis Nikolaos; Agelaki Sophia; Georgoulias Vassilis
Pooled analysis of elderly patients with non-small cell lung cancer treated with front line docetaxel/gemcitabine regimen: the Hellenic Oncology Research Group experience.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(5):505-10.
2008: Kakolyris S; Souglakos J; Polyzos A; Ardavanis A; Ziras N; Athanasiadis A; Varthalitis I; Amarantidis K; Tsousis S; Vamvakas L; Vardakis N; Georgoulias V;
Modified CAPOX (capecitabine plus oxaliplatin) regimen every two weeks as second-line treatment in patients with advanced colorectal cancer previously treated with irinotecan-based frontline therapy: a multicenter phase II study.
Oncology 2008;74(1-2):31-6.
2007: Xenidis N; Markos V; Apostolaki S; Perraki M; Pallis A; Sfakiotaki G; Papadatos-Pastos D; Kalmanti L; Kafousi M; Stathopoulos E; Kakolyris S; Mavroudis D; Georgoulias V
Clinical relevance of circulating CK-19 mRNA-positive cells detected during the adjuvant tamoxifen treatment in patients with early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(10):1623-31.
2007: Souglakos J; Vardakis N; Androulakis N; Kakolyris S; Kourousis C; Mavroudis D; Pallis A; Agelaki S; Kalbakis K; Georgoulias V
Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: a phase II trial.
Digestive diseases (Basel, Switzerland) 2007;25(1):100-5.
2006: Kakolyris Stylianos; Ziras Nikolaos; Vamvakas Lambros; Varthalitis John; Papakotoulas Pavlos; Syrigos Kostas; Vardakis Nikolaos; Kalykaki Antonia; Amarantidis Kiriakos; Georgoulias Vassilis
Gemcitabine plus oxaliplatin combination (GEMOX regimen) in pretreated patients with advanced non-small cell lung cancer (NSCLC): a multicenter phase II study.
Lung cancer (Amsterdam, Netherlands) 2006;54(3):347-52.
2006: Kakolyris S; Agelidou A; Androulakis N; Tsaroucha E; Kouroussis Ch; Agelidou M; Karvounis N; Veslemes M; Christophylakis Ch; Argyraki A; Geroyianni A; Georgoulias V
Cisplatin plus etoposide chemotherapy followed by thoracic irradiation and paclitaxel plus cisplatin consolidation therapy for patients with limited stage small cell lung carcinoma.
Lung cancer (Amsterdam, Netherlands) 2006;53(1):59-65.
2006: Souglakos J; Androulakis N; Syrigos K; Polyzos A; Ziras N; Athanasiadis A; Kakolyris S; Tsousis S; Kouroussis Ch; Vamvakas L; Kalykaki A; Samonis G; Mavroudis D; Georgoulias V
FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG).
British journal of cancer 2006;94(6):798-805.
2006: Amarantidis K; Houhouli K; Papatheodorou K; Miloussis A; Matthaios D; Chatzaki E; Lyrantzopoulos N; Tsaroucha A; Tentes A; Kakolyris S
A dose escalation study of docetaxel plus capecitabine in combination with gemcitabine in patients with advanced solid tumors.
Oncology research 2006;16(6):281-7.
2006: Kakolyris S; Kalbakis K; Potamianou A; Malamos N; Vamvakas L; Christophillakis C; Tselepatiotis E; Giassas S; Mavroudis D; Amarantidis K; Georgoulias V
Salvage chemotherapy with gemcitabine and oxaliplatin in heavily pretreated patients with metastatic breast cancer: a multicenter phase II study.
Oncology 2006;70(4):273-9.
2006: Kaklamanis Loukas; Trichas Miltiades; Amarantidis Kyriakos; Spathari Nikol; Micheli Anastasia; Karayiannakis Anastasios; Chatzaki Ekaterini; Georgoulias Vasilis; Kakolyris Stelios
VEGF expression in the colorectal adenoma-carcinoma sequence.
Oncology research 2006;15(9):445-51.
2005: Georgoulias Vassilis; Ardavanis Alexandros; Tsiafaki Xanthi; Agelidou Athina; Mixalopoulou Penelope; Anagnostopoulou Ourania; Ziotopoulos Panagiotis; Toubis Michael; Syrigos Kostas; Samaras Nikolaos; Polyzos Aris; Christou Anna; Kakolyris Stylianos; Kouroussis Charalambos; Androulakis Nikolaos; Samonis George; Chatzidaki Dora
Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(13):2937-45.
2005: Souglakos J; Vardakis N; Androulakis N; Kakolyris S; Kouroussis Ch; Mavroudis D; Pallis A; Agelaki S; Kalbakis K; Georgoulias V
Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: A phase II trial.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2005;10(1):47-52.
2005: Maltezos E; Amarantidis K; Trichas M; Vasiliadis M; Toromanidou M; Chatzaki E; Karayiannakis A; Tsaroucha A; Romanidis K; Kakolyris S
A dose escalation study of pegylated liposomal Doxorubicin (caelyx) in combination with capecitabine (xeloda) in patients with refractory solid tumors.
Oncology 2005;69(6):463-9.
2005: Souglakos J; Pallis A; Kakolyris S; Mavroudis D; Androulakis N; Kouroussis C; Agelaki S; Xenidis N; Milaki G; Georgoulias V
Combination of irinotecan (CPT-11) plus 5-fluorouracil and leucovorin (FOLFIRI regimen) as first line treatment for elderly patients with metastatic colorectal cancer: a phase II trial.
Oncology 2005;69(5):384-90.
2005: Souglakos John; Kakolyris Stylianos; Vardakis Nikolaos; Androulakis Nikolaos; Mavroudis Dimitrios; Vamvakas Lambos; Kouroussis Charalambos; Agelaki Sophia; Saridaki Zacharenia; Georgoulias Vassilis
A dose escalating study of oxaliplatin and high dose weekly leucovorin and 5-Fluorouracil in patients with advanced solid tumors.
Cancer investigation 2005;23(6):505-10.
2004: Kouroussis Charalambos; Mavroudis Dimitris; Kakolyris Stylianos; Voloudaki Argyro; Kalbakis Konstantinos; Souglakos John; Agelaki Sophia; Malas Konstantinos; Bozionelou Vassiliki; Georgoulias Vassilis
High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: results of a dose-finding study.
Lung cancer (Amsterdam, Netherlands) 2004;44(3):363-8.
2004: Giatromanolaki Alexandra; Koukourakis Michael I; Kakolyris Stelios; Mavroudis Dimitris; Kouroussis Charalambos; Mavroudi Chrysa; Perraki Maria; Sivridis Efthimios; Georgoulias Vassilis
Assessment of highly angiogenic and disseminated in the peripheral blood disease in breast cancer patients predicts for resistance to adjuvant chemotherapy and early relapse.
International journal of cancer. Journal international du cancer 2004;108(4):620-7.
2004: Kakolyris S; Souglakos J; Kouroussis C; Androulakis N; Samonis G; Vardakis N; Amarantidis K; Agelaki S; Mavroudis D; Xenidis N; Georgoulias V
Dose escalation study on oxaliplatin and capecitabine (Xeloda) in patients with advanced solid tumors.
Oncology 2004;66(4):253-9.
2003: Souglakos John; Androulakis Nikolaos; Mavroudis Dimitrios; Kourousis Charalabos; Kakolyris Stylianos; Vardakis Nikolaos; Kalbakis Konstantinos; Pallis Athanasios; Ardavanis Alexandros; Varveris Charalabos; Georgoulias Vassilios
Multicenter dose-finding study of concurrent capecitabine and radiotherapy as adjuvant treatment for operable rectal cancer.
International journal of radiation oncology, biology, physics 2003;56(5):1284-7.
2003: Xenidis N; Vlachonikolis I; Mavroudis D; Perraki M; Stathopoulou A; Malamos N; Kouroussis C; Kakolyris S; Apostolaki S; Vardakis N; Lianidou E; Georgoulias V
Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(6):849-55.
2003: Mavroudis D; Pappas P; Kouroussis C; Kakolyris S; Agelaki S; Kalbakis K; Androulakis N; Souglakos J; Vardakis N; Nikolaidou M; Samonis G; Marselos M; Georgoulias V
A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(2):304-12.
2003: Kouroussis Charalambos; Agelaki Sophia; Mavroudis Dimitris; Kakolyris Stylianos; Androulakis Nick; Kalbakis Kostas; Souglakos John; Mallas Kostas; Bozionelou Vassiliki; Pallis Athanasios; Adamtziki Helen; Georgoulias Vassilis
A dose escalation study of docetaxel and oxaliplatin combination in patients with metastatic breast and non-small cell lung cancer.
Anticancer research 2003;23(1B):785-91.
2003: Mavroudis D; Pavlakou G; Blazoyiannakis G; Veslemes M; Apostolopoulou F; Kouroussis Ch; Kakolyris S; Agelaki S; Androulakis N; Vardakis N; Magkanas E; Samonis G; Georgoulias V
Sequential administration of cisplatin-etoposide followed by topotecan in patients with extensive stage small cell lung cancer. A multicenter phase II study.
Lung cancer (Amsterdam, Netherlands) 2003;39(1):71-6.
2002: Kouroussis Charalambos; Souglakos John; Mavroudis Dimitris; Papadouris Savvakis; Kakolyris Stylianos; Agelaki Sophia; Kalbakis Kostas; Panopoulos Christos; Vardakis Nikos; Sarra Evanthia; Georgoulias Vassilis
Oxaliplatin with high-dose leucovorin and infusional 5-fluorouracil in irinotecan-pretreated patients with advanced colorectal cancer (ACC).
American journal of clinical oncology 2002;25(6):627-31.
2002: Giannakakis Theodore; Kakolyris Stelios; Theodoropoulos Elias; Kouroussis Charalambos; Michailakis Emmanuel; Papadouris Savvakis; Tsitoura Miranda; Kalbakis Kostas; Souglakos John; Agelaki Sohia; Vardakis Nikos; Georgoulias Vassilis
A multicenter phase II study of docetaxel and carboplatin combination as front-line treatment in advanced non-small cell lung cancer.
Anticancer research 2002;22(6B):3743-8.
2002: Androulakis N; Kouroussis C; Mavroudis D; Kakolyris S; Souglakos J; Agelaki S; Kalbakis K; Malas K; Pallis A; Samonis G; Georgoulias V
Phase I study of weekly paclitaxel and liposomal doxorubicin in patients with advanced solid tumours.
European journal of cancer (Oxford, England : 1990) 2002;38(15):1992-7.
2002: Souglakos John; Kotsakis Athanaslos; Kouroussis Charalambos; Kakolyris Stylianos; Mavroudis Dimitrios; Kalbakis Konstadinos; Agelaki Sofia; Vlachonikolis John; Georgoulias Vassilis; Samonis George
Nonneutropenic febrile episodes associated with docetaxel-based chemotherapy in patients with solid tumors.
Cancer 2002;95(6):1326-33.
2002: Stathopoulou A; Vlachonikolis I; Mavroudis D; Perraki M; Kouroussis Ch; Apostolaki S; Malamos N; Kakolyris S; Kotsakis A; Xenidis N; Reppa D; Georgoulias V
Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(16):3404-12.
2002: Souglakos J; Mavroudis D; Kakolyris S; Kourousis Ch; Vardakis N; Androulakis N; Agelaki S; Kalbakis K; Tsetis D; Athanasiadis N; Samonis G; Georgoulias V
Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(11):2651-7.
2002: Vamvakas L; Kakolyris S; Kouroussis C; Kandilis K; Mavroudis D; Ziras N; Androulakis N; Kalbakis K; Sarra E; Souglakos J; Georgoulias V;
Irinotecan (CPT-11) in combination with infusional 5-fluorouracil and leucovorin (de Gramont regimen) as first-line treatment in patients with advanced colorectal cancer: a multicenter phase II study.
American journal of clinical oncology 2002;25(1):65-70.
2002: Koukourakis Michael I; Giatromanolaki Alexandra; Kouroussis Charalambos; Kakolyris Stelios; Sivridis Efthimios; Frangiadaki Chryssi; Retalis George; Georgoulias Vassilis;
Hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC): a short, safe, and effective postoperative regimen for high-risk breast cancer patients.
International journal of radiation oncology, biology, physics 2002;52(1):144-55.
2002: Kakolyris S; Kouroussis C; Koukourakis M; Mavroudis D; Malas K; Vardakis N; Bozionelou V; Kalbakis K; Georgoulias V
A dose-escalation study of oxaliplatin and vinorelbine in patients with advanced solid tumors.
Oncology 2002;63(3):213-8.
2002: Mavroudis D; Kouroussis Ch; Kakolyris S; Agelaki S; Kalbakis K; Androulakis N; Souglakos J; Samonis G; Georgoulias V
Phase I study of paclitaxel (taxol) and pegylated liposomal doxorubicin (caelyx) administered every 2 weeks in patients with advanced solid tumors.
Oncology 2002;62(3):216-22.
2001: Kakolyris S; Kouroussis C; Souglakos J; Agelaki S; Kalbakis K; Vardakis N; Vamvakas L; Georgoulias V
Cisplatin and irinotecan (CPT-11) as second-line treatment in patients with advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2001;34 Suppl 4():S71-6.
2001: Georgoulias V; Samonis G; Papadakis E; Alexopoulos A; Tsiafaki X; Rapti A; Veslemes M; Grigoratou T; Palamidas P; Kouroussis C; Mavroudis D; Kakolyris S; Giannakakis T; Vlachonikolis J;
Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer: early results of a randomized trial.
Lung cancer (Amsterdam, Netherlands) 2001;34 Suppl 4():S47-51.
2001: Kakolyris S; Giatromanolaki A; Koukourakis M; Kaklamanis L; Kouroussis C H; Bozionelou V; Georgoulias V; Gatter K C; Harris A L
Assessment of vascular maturation in lung and breast carcinomas using a novel basement membrane component, LH39.
Anticancer research 2001;21(6B):4311-6.
2001: Papakostas P; Kouroussis C; Androulakis N; Samelis G; Aravantinos G; Kalbakis K; Sarra E; Souglakos J; Kakolyris S; Georgoulias V
First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study.
European journal of cancer (Oxford, England : 1990) 2001;37(15):1833-8.
2001: Agelaki S; Kakolyris S; Palamidas P; Kouroussis C; Mavroudis D; Kalbakis K; Georgoulias V; Raptis A
A dose escalation study of topotecan in combination with epirubicin in pretreated patients with small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2001;34(1):133-9.
2001: Kalbakis K; Kouroussis C; Kakolyris S; Mavroudis D; Souglakos J; Agelaki S; Vamvakas L; Christodoulakis M; Stylianou K; Georgoulias V
Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanes.
British journal of cancer 2001;85(6):798-802.
2001: Kouroussis C; Kakolyris S; Mavroudis D; Androulakis N; Kalbakis K; Agelaki S; Sarra E; Souglakos J; Christodoulakis M; Samonis G; Georgoulias V
A dose-finding study of the weekly administration of paclitaxel in patients with advanced solid tumors.
American journal of clinical oncology 2001;24(4):404-7.
2001: Alexopoulos A; Kouroussis C; Malamos N; Kakolyris S; Kalbakis K; Kosmas C; Mavroudis D; Agelaki S; Vlachonicolis J; Sarra E; Rigatos G; Georgoulias V
Docetaxel in combination with mitoxantrone and granulocyte colony-stimulating factor as front-line chemotherapy in metastatic breast cancer: a multicenter phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(6):793-8.
2001: Kakolyris S; Papadakis E; Tsiafaki X; Kalofonos C; Rapti A; Toubis M; Bania E; Kouroussis C; Chainis K; Androulakis N; Agelaki S; Sarra E; Vardakis N; Georgoulias V;
Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study.
Lung cancer (Amsterdam, Netherlands) 2001;32(2):179-87.
2001: Koukourakis M I; Giatromanolaki A; Kakolyris S; Sivridis E; Georgoulias V; Funtzilas G; Hickson I D; Gatter K C; Harris A L
Nuclear expression of human apurinic/apyrimidinic endonuclease (HAP1/Ref-1) in head-and-neck cancer is associated with resistance to chemoradiotherapy and poor outcome.
International journal of radiation oncology, biology, physics 2001;50(1):27-36.
2001: Mavroudis D; Papadakis E; Veslemes M; Tsiafaki X; Stavrakakis J; Kouroussis C; Kakolyris S; Bania E; Jordanoglou J; Agelidou M; Vlachonicolis J; Georgoulias V;
A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(4):463-70.
2001: Stathopoulos G P; Mavroudis D; Tsavaris N; Kouroussis C; Aravantinos G; Agelaki S; Kakolyris S; Rigatos S K; Karabekios S; Georgoulias V
Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: a phase II study of the Greek Cooperative Group for Pancreatic Cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(1):101-3.
2001: Kouroussis C; Souglakos J; Kakolyris S; Mavroudis D; Malamos N; Kalbakis K; Androulakis N; Agelaki A; Vardakis N; Samonis G; Georgoulias V
Oxaliplatin in combination with infusional 5-fluorouracil and leucovorin every 2 weeks as first-line treatment in patients with advanced colorectal cancer: a phase II study.
Oncology 2001;61(1):36-41.
2001: Kakolyris S; Souglakos J; Kouroussis C; Androulakis N; Mavroudis D; Kalbakis K; Kotsakis A; Vardakis N; Koukourakis M; Romanos J; Georgoulias V
A dose-finding study of irinotecan (CPT-11) plus a four-day continuous 5-fluorouracil infusion in advanced colorectal cancer.
Oncology 2001;60(3):207-13.
2000: Kakolyris S; Souglakos J; Agelaki S; Kourousis C H; Mavroudis D; Sarra E; Malliotakis P; Georgoulias V
A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapy.
Lung cancer (Amsterdam, Netherlands) 2000;30(3):193-8.
2000: Mavroudis D; Alexopoulos A; Ziras N; Malamos N; Kouroussis C; Kakolyris S; Agelaki S; Kalbakis K; Tsavaris N; Potamianou A; Rigatos G; Georgoulias V
Front-line treatment of advanced breast cancer with docetaxel and epirubicin: a multicenter phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(10):1249-54.
2000: Mavroudis D; Kourousis C; Androulakis N; Kalbakis K; Agelaki S; Kakolyris S; Souglakos J; Sarra E; Vardakis N; Hatzidaki D; Sarmonis G; Georgoulias V
Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF): a phase II trial.
American journal of clinical oncology 2000;23(4):341-4.
2000: Kakolyris S; Kouroussis C; Kalbakis K; Mavroudis D; Souglakos J; Nvardakis; Kremos S; Georgoulias V
Salvage treatment of advanced non-small-cell lung cancer previously treated with docetaxel-based front-line chemotherapy with irinotecan (CPT-11) in combination with cisplatin.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(6):757-60.
2000: Kouroussis C; Samonis G; Androulakis N; Souglakos J; Voloudaki A; Dimopoulos M A; Kotsakis T; Kakolyris S; Kalbakis K; Georgoulias V
Successful conservative treatment of neutropenic enterocolitis complicating taxane-based chemotherapy: a report of five cases.
American journal of clinical oncology 2000;23(3):309-13.
2000: Koukourakis M I; Giatromanolaki A; Thorpe P E; Brekken R A; Sivridis E; Kakolyris S; Georgoulias V; Gatter K C; Harris A L
Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer.
Cancer research 2000;60(11):3088-95.
2000: Koukourakis M I; Kyrias G; Kakolyris S; Kouroussis C; Frangiadaki C; Giatromanolaki A; Retalis G; Georgoulias V
Subcutaneous administration of amifostine during fractionated radiotherapy: a randomized phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(11):2226-33.
2000: Koukourakis M I; Giatromanolaki A; Kakolyris S; Froudarakis M; Georgoulias V; Retalis G; Bahlitzanakis N
Phase I/II dose escalation study of docetaxel and carboplatin combination supported with amifostine and GM-CSF in patients with incomplete response following docetaxel chemo-radiotherapy: additional chemotherapy enhances regression of residual cancer.
Medical oncology (Northwood, London, England) 2000;17(2):135-43.
2000: Kanavaros P; Stefanaki K; Vlachonikolis J; Eliopoulos G; Kakolyris S; Rontogianni D; Gorgoulis V; Georgoulias V
Expression of p53, p21/waf1, bcl-2, bax, Rb and Ki67 proteins in Hodgkin's lymphomas.
Histology and histopathology 2000;15(2):445-53.
2000: Giannakakis T; Ziras N; Kakolyris S; Mavroudis D; Androulakis N; Agelaki S; Parashos M; Sarra E; Dimou T; Hatzidaki D; Vlachonikolis J; Georgoulias V
Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma: a multicentre phase I study.
European journal of cancer (Oxford, England : 1990) 2000;36(6):742-7.
2000: Mavroudis D; Kourousis C; Kakolyris S; Agelaki S; Kalbakis K; Androulakis N; Souglakos J; Vardakis N; Samonis G; Georgoulias V
Phase I study of the gemcitabine/oxaliplatin combination in patients with advanced solid tumors: a preliminary report.
Seminars in oncology 2000;27(1 Suppl 2):25-30.
2000: Koukourakis M I; Giatromanolaki A; Guddo F; Kaklamanis L; Vignola M; Kakolyris S; Turley H; Georgoulias V; Bonsignore G; Gatter K C; Harris A L
c-erbB-2 and episialin challenge host immune response by HLA class I expression in human non-small-cell lung cancer.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2000;23(1):104-14.
2000: Kakolyris S A; Kaklamanis L G; Koukourakis M J; Giatromanolaki A; Rousomoustakaki M; Souglakos J C; Reppa D K; Georgoulias V A; Gatter K C; Harris A L
Angiogenesis and p53 expression in the colorectal adenoma-carcinoma sequence.
Oncology research 2000;12(4):203-8.
2000: Kouroussis C; Agelaki S; Mavroudis D; Souglakos J; Kakolyris S; Kalbakis K; Vardakis N; Reppa D; Hatzidaki D; Samonis G; Georgoulias V
A dose escalation study of weekly docetaxel in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2000;46(6):488-92.
2000: Kaklamanis L; Kakolyris S; Koukourakis M; Gatter K C; Harris A L
From hyperplasia to neoplasia and invasion: angiogenesis in the colorectal adenoma-carcinoma model.
Advances in experimental medicine and biology 2000;476():249-66.
1999: Kakolyris S; Kourousis C; Koukourakis M; Androulakis N; Vamvakas L; Agelaki S; Hatzidaki D; Samonis G; Tsiftsis D; Georgoulias V
First-line treatment of metastatic breast cancer with mitoxantrone, vinorelbine, and carboplatin.
American journal of clinical oncology 1999;22(6):568-72.
1999: Kakolyris S; Giatromanolaki A; Koukourakis M; Leigh I M; Georgoulias V; Kanavaros P; Sivridis E; Gatter K C; Harris A L
Assessment of vascular maturation in non-small cell lung cancer using a novel basement membrane component, LH39: correlation with p53 and angiogenic factor expression.
Cancer research 1999;59(21):5602-7.
1999: Kakolyris S; Giatromanolaki A; Koukourakis M; Kaklamanis L; Kanavaros P; Hickson I D; Barzilay G; Georgoulias V; Gatter K C; Harris A L
Nuclear localization of human AP endonuclease 1 (HAP1/Ref-1) associates with prognosis in early operable non-small cell lung cancer (NSCLC).
The Journal of pathology 1999;189(3):351-7.
1999: Androulakis N; Kourousis C; Dimopoulos M A; Samelis G; Kakolyris S; Tsavaris N; Genatas K; Aravantinos G; Papadimitriou C; Karabekios S; Stathopoulos G P; Georgoulias V
Treatment of pancreatic cancer with docetaxel and granulocyte colony-stimulating factor: a multicenter phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(6):1779-85.
1999: Kakolyris S; Samonis G; Koukourakis M; Vlachonicolis J; Kalbakis K; Agelaki S; Chalkiadakis G; Sanidas E; Tsiftsis D; Georgoulias V
First-line treatment with mitoxantrone, methotrexate, vincristine, and carboplatine (MIMOC) plus cyclical hormonotherapy with tamoxifen and megestrol acetate in advanced breast cancer.
American journal of clinical oncology 1999;22(3):273-7.
1999: Kouroussis C; Xydakis E; Potamianou A; Giannakakis T; Kakolyris S; Agelaki S; Sara E; Malamos N; Alexopoulos A; Mavroudis D; Samonis G; Papadouris S; Georgoulias V; Panagos G
Front-line treatment of metastatic breast cancer with docetaxel and epirubicin: a multicenter dose-escalation study. The Greek Breast Cancer Cooperative Group (GBCCG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(5):547-52.
1999: Kanavaros P; Stefanaki K; Valassiadou K; Vlachonikolis J; Mavromanolakis M; Vlychou M; Kakolyris S; Gorgoulis V; Tzardi M; Georgoulias V
Expression of p53, p21/waf, bcl-2, bax, Rb and Ki67 proteins in colorectal adenocarcinomas.
Medical oncology (Northwood, London, England) 1999;16(1):23-30.
1999: Georgoulias V; Kouroussis C; Androulakis N; Kakolyris S; Dimopoulos M A; Papadakis E; Bouros D; Apostolopoulou F; Papadimitriou C; Agelidou A; Hatzakis K; Kalbakis K; Kotsakis A; Vardakis N; Vlachonicolis J
Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):914-20.
1999: Kouroussis C; Androulakis N; Kakolyris S; Souglakos J; Kotsakis T; Mavroudis D; Katsogridakis K; Vardakis N; Hatzidaki D; Samonis G; Vlachonikolis J; Georgoulias V
Dose-escalation study of docetaxel in combination with mitoxantrone as first-line treatment in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):862-9.
1999: Mavroudis D; Malamos N; Alexopoulos A; Kourousis C; Agelaki S; Sarra E; Potamianou A; Kosmas C; Rigatos G; Giannakakis T; Kalbakis K; Apostolaki F; Vlachonicolis J; Kakolyris S; Samonis G; Georgoulias V
Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: a multicenter phase II trial. Greek Breast Cancer Cooperative Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(2):211-5.
1999: Sara E; Kotsakis A; Souklakos J; Kourousis C; Kakolyris S; Mavromanolakis E; Vlachonicolis J; Georgoulias V
Post-chemotherapy lymphopoiesis in patients with solid tumors is characterized by CD4+ cell proliferation.
Anticancer research 1999;19(1A):471-6.
1999: Koukourakis M I; Giatromanolaki A; Schiza S; Kakolyris S; Georgoulias V
Concurrent twice-a-week docetaxel and radiotherapy: a dose escalation trial with immunological toxicity evaluation.
International journal of radiation oncology, biology, physics 1999;43(1):107-14.
1999: Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V
Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.
Clinical and experimental pathology 1999;47(5):231-8.
1999: Alexopoulos K; Kouroussis C; Androulakis N; Papadakis E; Vaslamatzis M; Kakolyris S; Samelis G; Patila E; Vossos A; Samantas E; Georgoulias V
Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial.
Cancer chemotherapy and pharmacology 1999;43(3):257-62.
1998: Kakolyris S; Kaklamanis L; Giatromanolaki A; Koukourakis M; Hickson I D; Barzilay G; Turley H; Leek R D; Kanavaros P; Georgoulias V; Gatter K C; Harris A L
Expression and subcellular localization of human AP endonuclease 1 (HAP1/Ref-1) protein: a basis for its role in human disease.
Histopathology 1998;33(6):561-9.
1998: Kourousis C; Androulakis N; Kakolyris S; Souglakos J; Maltezakis G; Metaxaris G; Chalkiadakis G; Samonis G; Vlachonikolis J; Georgoulias V
First-line treatment of advanced nonsmall cell lung carcinoma with docetaxel and vinorelbine.
Cancer 1998;83(10):2083-90.
1998: Giatromanolaki A; Fountzilas G; Koukourakis M I; Arapandoni P; Theologi V; Kakolyris S; Georgoulias V; Harris A L; Gatter K C
Neo-angiogenesis in locally advanced squamous cell head and neck cancer correlates with thymidine phosphorylase expression and p53 nuclear oncoprotein accumulation.
Clinical & experimental metastasis 1998;16(7):665-72.
1998: Androulakis N; Kouroussis C; Kakolyris S; Tzannes S; Papadakis E; Papadimitriou C; Geroyianni A; Georgopoulou T; Dimopoulou I; Souglakos J; Kotsakis A; Vardakis N; Hatzidaki D; Georgoulias V
Salvage treatment with paclitaxel and gemcitabine for patients with non-small-cell lung cancer after cisplatin- or docetaxel-based chemotherapy: a multicenter phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(10):1127-30.
1998: Kakolyris S; Samonis G; Koukourakis M; Vlachonicolis I; Chalkiadakis G; Kalbakis K; Souglakos I; Agelaki S; Toloudis P; Georgoulias V
Treatment of non-small-cell lung cancer with prolonged oral etoposide.
American journal of clinical oncology 1998;21(5):505-8.
1998: Stefanaki K; Tzardi M; Kouvidou C; Chaniotis V; Bolioti M; Vlychou M; Zois M; Kakolyris S; Delides G; Rontogianni D; Georgoulias V; Kanavaros P
Expression of p53, p21, mdm2, Rb, bax and Ki67 proteins in lymphomas of the mucosa-associated lymphoid (MALT) tissue.
Anticancer research 1998;18(4A):2403-8.
1998: Kourousis C; Kakolyris S; Androulakis N; Heras P; Vlachonicolis J; Vamvakas L; Vlata M; Hatzidaki D; Samonis G; Georgoulias V
Salvage chemotherapy with paclitaxel, vinorelbine, and cisplatin (PVC) in anthracycline-resistant advanced breast cancer.
American journal of clinical oncology 1998;21(3):226-32.
1998: Koukourakis M I; Kourousis C; Kamilaki M; Koukouraki S; Giatromanolaki A; Kakolyris S; Kotsakis A; Androulakis N; Bahlitzanakis N; Georgoulias V
Weekly docetaxel and concomitant boost radiotherapy for non-small cell lung cancer. A phase I/II dose escalation trial.
European journal of cancer (Oxford, England : 1990) 1998;34(6):838-44.
1998: Stefanaki K; Rontogiannis D; Vamvouka C; Bolioti S; Chaniotis V; Sotsiou F; Vlychou M; Delidis G; Kakolyris S; Georgoulias V; Kanavaros P
Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomas.
Anticancer research 1998;18(3A):1689-95.
1998: Koukourakis M I; Giatromanolaki A; Kakolyris S; O'Byrne K J; Apostolikas N; Skarlatos J; Gatter K C; Harris A L
Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival.
British journal of cancer 1998;77(10):1696-703.
1998: Kakolyris S; Kaklamanis L; Engels K; Fox S B; Taylor M; Hickson I D; Gatter K C; Harris A L
Human AP endonuclease 1 (HAP1) protein expression in breast cancer correlates with lymph node status and angiogenesis.
British journal of cancer 1998;77(7):1169-73.
1998: Stefanaki K; Rontogiannis D; Vamvouka C; Bolioti S; Chaniotis V; Sotsiou F; Vlychou M; Delidis G; Kakolyris S; Georgoulias V; Kanavaros P
Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomas.
Anticancer research 1998;18(2A):1167-73.
1998: Georgoulias V; Androulakis N; Dimopoulos A M; Kourousis C; Kakolyris S; Papadakis E; Apostolopoulou F; Papadimitriou C; Vossos A; Agelidou M; Heras P; Tzannes S; Vlachonicolis J; Mavromanolakis E; Hatzidaki D
First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: a multicenter phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(3):331-4.
1998: Giatromanolaki A; Koukourakis M I; Kakolyris S; Kaklamanis L; Barbatis K; O'Byrne K J; Theodosssiou D; Harris A L; Gatter K C
Focal expression of thymidine phosphorylase associates with CD31 positive lymphocytic aggregation and local neo-angiogenesis in non-small cell lung cancer.
Anticancer research 1998;18(1A):71-6.
1998: Kaklamanis L; Kakolyris S; Turley H; Koukourakis M; Biddolph S; Gatter K C; Harris A L
Neoplastic stroma and epithelium show up-regulation of platelet-derived endothelial cell growth factor/thymidine phosphorylase in colorectal carcinomas but not adenomas.
Angiogenesis 1998;2(1):49-55.
1997: Georgoulias V; Kourousis C; Androulakis N; Kakolyris S; Dimopoulos M A; Bouros D; Papadimitriou C; Hatzakis K; Heras P; Kalbakis K; Kotsakis T; Vardakis N; Meramveliotakis N; Hatzidaki D
Docetaxel (Taxotere) and gemcitabine in the treatment of non-small cell lung cancer: preliminary results.
Seminars in oncology 1997;24(4 Suppl 14):S14-22-S14-25.
1997: Georgoulias V; Kourousis C; Androulakis N; Kakolyris S; Papadakis E; Bouros D; Apostolopoulou F; Georgopoulou T; Agelidou M; Souglakos J; Halkiadakis G; Hatzidaki D
Docetaxel (Taxotere) and vinorelbine in the treatment of non-small cell lung cancer.
Seminars in oncology 1997;24(4 Suppl 14):S14-9-S14-14.
1997: Georgoulias V; Kourousis C; Kakolyris S; Androulakis N; Dimopoulos M A; Papadakis E; Kotsakis T; Vardakis N; Kalbakis K; Merambeliotakis N; Hatzidaki D
Second-line treatment of advanced non-small cell lung cancer with paclitaxel and gemcitabine: a preliminary report on an active regimen.
Seminars in oncology 1997;24(4 Suppl 12):S12-61-S12-66.
1997: Kouvidou C; Stefanaki K; Dai Y; Tzardi M; Koutsoubi K; Darivianaki K; Karidi E; Rontogianni D; Zois E; Kakolyris S; Georgoulias V; Delides G; Kanavaros P
P21/waf1 protein expression in nasopharyngeal carcinoma. Comparative study with PCNA, p53 and MDM-2 protein expression.
Anticancer research 1997;17(4A):2615-9.
1997: Giannikaki E; Kouvidou C; Tzardi M; Stefanaki K; Koutsoubi K; Gregoriou M; Zois E; Kakolyris S; Mavroudi C; Delides G; Georgoulias V; Kanavaros P
p53 protein expression in breast carcinomas. Comparative study with the wild type p53 induced proteins mdm2 and p21/waf1.
Anticancer research 1997;17(3C):2123-7.
1997: Kakolyris S; Kaklamanis L; Engels K; Turley H; Hickson I D; Gatter K C; Harris A L
Human apurinic endonuclease 1 expression in a colorectal adenoma-carcinoma sequence.
Cancer research 1997;57(9):1794-7.
1996: Tzardi M; Kouvidou C; Panayiotides I; Koutsoubi K; Stefanaki K; Giannikaki E; Darivianaki K; Zois M; Eliopoulos G; Kakolyris S; Delides G; Rontogianni D; Kanavaros P
Expression of p53 and mdm-2 proteins in Hodgkin's Disease. Absence of correlation with the presence of Epstein-Barr virus.
Anticancer research 1996;16(5A):2813-9.
1995: Kakolyris S; Karakitsos P; Tzardi M; Agapitos E
Immunohistochemical detection of fibronectin in early and advanced atherosclerosis.
In vivo (Athens, Greece) 1995;9(1):35-40.
1994: Tsilivakos V; Tsapis A; Kakolyris S; Iliakis P; Perraki M; Georgoulias V
Characterization of interleukin 2 receptors on B-cell chronic lymphocytic leukemia cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(9):1571-8.
1992: Mylonakis N; Tsavaris N; Bacoyiannis C; Karvounis N; Kakolyris S; Karabelis A; Beer M; Kosmidis P
A randomized prospective study of cisplatin and vinblastine versus cisplatin, vinblastine and mitomycin in advanced non-small cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(2):127-30.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Stylianos Kakolyris

Research Profile (preview)

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Stylianos Kakolyris (preview)

All Publications